Definitive Contract 75D30121C11569
Award Date
7/1/21
Potential Completion Date
12/31/22
Potential Value
$452K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price federal contract, valued at $393,011.00, was awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of the University of Pennsylvania (Penn) to conduct a respiratory microbiome study. The contract does not have a set-aside designation. Penn, a renowned private research university and academic medical center, has a long history of performing advanced biomedical research and providing healthcare services to the federal government through contracts and...
The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), awarded a $683,280 firm-fixed-price contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, for a project titled "Targeted Reduction of Antimicrobials". This contract, which does not have a set-aside designation, was awarded on September 14, 2016 with a completion date of June 19, 2018. The University of...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $481,788.00 definitive contract to The Trustees of the University of Pennsylvania (Penn), a private university and non-profit organization, to conduct research related to antibiotic resistant drugs and long-term acute care patients. This is a cost-no-fee contract with a completion date of September 18, 2019. Penn has a history of receiving federal research and development funding from agencies such...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, for a Stool Microbiome Study. The contract has a ceiling value of $263,231 and was awarded on September 9, 2016, with a completion date of September 14, 2017. The contract is a firm fixed-price arrangement. The University of Pennsylvania is a renowned private research university...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $598,990.00 firm-fixed-price definitive contract to The Trustees of the University of Pennsylvania (Penn) to conduct research on colonization with multidrug-resistant gram-negative bacteria in Botswana. The contract was awarded on September 30, 2018 and has a completion date of September 29, 2020. Penn is a private university and non-profit organization that conducts biomedical research, provides...
The University of Pennsylvania will deliver research services to the Centers for Disease Control and Prevention under a three-year, $672,276 firm fixed price contract. Awarded through the Department of Health and Human Services' Broad Agency Announcement 2020 Topic 3.1 solicitation, the University will support CDC programs in Philadelphia, conducting work aligned with the agency's disease prevention and public health missions. As the prime contractor, the University of Pennsylvania's Clinical...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $564,294 firm fixed price definitive contract to The Trustees of the University of Pennsylvania, operating as the University of Pennsylvania, to study the epidemiology and outcomes associated with COVID-19 infection. The contract has a completion date of December 31, 2022 and was awarded on January 6, 2021. The University of Pennsylvania is a private university and non-profit organization that...
This is a $745,301.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract supports FY21 Broad Agency Announcement (BAA) Topic 8 research, which is civilian in nature and has no set-aside designation. The period of performance runs through May 14, 2022. The Trustees of the University of Pennsylvania, a private university and...
The Pennsylvania State University (Penn State) was awarded a $1.23 million cost-no-fee contract by the Centers for Disease Control and Prevention (CDC) to conduct whole-genome sequencing of Bacilli isolates. Under the FY2021 Broad Agency Announcement Topic 3, Penn State will sequence the isolates using Oxford Nanopore Technologies' MinION MK1C sequencing devices and associated flow cells, barcoding kits, and priming kits provided by Oxford Nanopore Technologies Inc. as a major subcontractor. The...
This is a $1,388,563.00 firm fixed-price delivery order awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract is part of the Safe Healthcare, Epidemiology, and Prevention Research Development Program (SHEPheRD) IDIQ, which supports the CDC's infectious disease research objectives. The award does not have a set-aside...